Condition: Multi Drug Resistant Organisms · Sponsor: Valeriu Gheorghita
This study aims to evaluate the impact of digestive carriage of multidrug-resistant organisms (MDRO) on the risk of healthcare-associated infections in hospitalized adult patients. Patients will be screened at admission, weekly, and at discharge, with a 30-day post-discharge follow-up. The findings will support infection prevention and control strategies in Romanian hospitals.
This description comes directly from the study's public registry record.
Valeriu Gheorghita, Prof. Univ. · +40377720000 · secretariat.agrippa@dcti.ro
Ana Dobrin, Dr. · +40745325335 · dr.ana.dobrin@gmail.com
Always discuss trial participation with your own doctor first.
| Emergency and Clinical Hospital Dr. Agrippa Ionescu | Bucharest, Bucharest, Romania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07134270